Company intelligence / Profile preview

Hylogic

Riverside, Missouri, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Hylogic is a specialized biotechnology and nutraceutical company focused on the development of high molecular weight hyaluronic acid (HA) products for human and animal health. Founded in 2002, the company has pioneered the use of oral HA supplements to support joint lubrication, skin hydration, and ocular health. Their extensive product portfolio includes well-known brands such as Hyalun for joint support and Episilk for dermatological care. Hylogic leverages its expertise in HA science to provide non-invasive, biocompatible solutions for maintaining connective tissue integrity and overall wellness.

Therapeutic areas: OphthalmologyRheumatologyDermatology
Modalities: Biologic
Industry: Biotech

Beyond the preview

Go deeper on Hylogic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hylogic.

Explore the full profile